Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v8-FR Version v2-FR
Language French French
Date Updated 2024-04-24 2022-10-11
Drug Identification Number 02262819 02262819
Brand name STRATTERA STRATTERA
Common or Proper name atomoxetine capsules atomoxetine capsules
Company Name ELI LILLY CANADA INC ELI LILLY CANADA INC
Ingredients ATOMOXETINE ATOMOXETINE
Strength(s) 18MG 18MG
Dosage form(s) CAPSULE CAPSULE
Route of administration ORAL ORAL ORAL ORAL
Packaging size Blister package of 28 capsules Blister package of 28 capsules
ATC code N06BA N06BA
ATC description PSYCHOSTIMULANTS AND NOOTROPICS PSYCHOSTIMULANTS AND NOOTROPICS
Reason for discontinuation Business reasons Business reasons
Anticipated discontinuation date 2024-04-23 2023-11-01
Actual discontinuation date 2024-04-23
Remaining supply date 2024-04-23 2023-11-01
Discontinuation status Discontinued To be discontinued
Discontinuation decision reversal no no
Tier 3 Status No No
Information on remaining supply
Company comments For any questions, please contact our Customer Response Centre at 1-888-545-5972 (Monday-Friday, 9 a.m. to 5 p.m. Eastern Time, excluding holidays). For any questions, please contact our Customer Response Centre at 1-888-545-5972 (Monday-Friday, 9 a.m. to 5 p.m. Eastern Time, excluding holidays).
Health Canada comments